Study of possible combined toxic effects of azaspiracid-1 and okadaic acid in mice via the oral route

Toxicon

Volumn 60, Issue 5, 2012, Pages 895-906

  Aune, Tore ^a   Espenes, Arild ^a   Aasen, John A Bunæs ^a   Quilliam, Michael A ^b   Hess, Philipp ^c,d   Larsen, Stig ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MARINE INSTITUTE   (Ireland)

^d IFREMER   (France)

Author keywords

Azaspiracid; Okadaic acid; Toxicity

Indexed keywords

AZASPIRACID; AZASPIRACID 1; OKADAIC ACID; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD CONTAMINATION; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TOXICITY; LD 50; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHELLFISH POISONING; TISSUE LEVEL; TOXICOKINETICS; TOXIN ANALYSIS;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, LIQUID; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL TRACT; LETHAL DOSE 50; MARINE TOXINS; MICE; OKADAIC ACID; SHELLFISH; SHELLFISH POISONING; SPIRO COMPOUNDS; TANDEM MASS SPECTROMETRY;

MUS;

EID: 84864067373     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2012.06.007     Document Type: Article

References (21)

1. Aasen J.A.B., Espenes A., Hess P., Aune T. Sub-lethal dosing of azaspiracid-1 in female NMRI mice. Toxicon 2010, 56:1419-1425.
2. Anonymous Commission Decision 2002/225/EC of 15 March 2002 laying down detailed rules for the implementation of Council Directive 91/492/EEC as regards the maximum levels and the methods of analysis of certain marine biotoxins in bivalve molluscs, echinoderms, tunicates and marine gastropods. Official Journal 16/3/2002, L75:62-64.
3. Anonymous Commission Regulation (EU) No 15/2011 of 10 January 2011 amending Regulation (EC) No 2074/2005 as regards recognised testing methods for detecting marine biotoxins in live bivalve molluscs. Official Journal 11/1/2011, L6:3-6.
4. Aune T., Larsen S., Aasen J.A.B., Rehmann N., Satake M., Hess P. Relative toxicity of dinophysistoxin-2 (DTX2) compared with okadaic acid, based on acute intraperitoneal toxicity in mice. Toxicon 2007, 1-7.
5. Babb J., Rogatko A., Zacks S. Cancer phase I clinical trials: efficient dose escalation with overdose control. Statistics in Medicine 1998, 17:1103-1120.
6. Dewi, S., Aune, T., Aasen, J.A.B., Smith, A. and Larsen, S. Response Surface Pathway design in Laboratory animals exemplified by estimation of LD50 of marine biotoxins, submitted for publication.
7. EFSA Opinion of the scientific panel on contaminants in the food chain on a request from the European Commission on marine biotoxins in shellfish - okadaic acid and analogues. The EFSA Journal 2008, 589:1-62.
8. EFSA Opinion of the Scientific Panel on contaminants in the food chain on a request from the European Commission on marine biotoxins in shellfish - azaspiracids. The EFSA Journal 2008, 723:1-52.
9. Flanagan A.F., Callanan K.R., Donlon J., Palmer R., Forde A., Kane M. A cytotoxicity assay for the detection and differentiation of two families of shellfish toxins. Toxicon 2001, 39:1021-1027.
10. Ito E., Satake M., Ofuji K., Kurita N., McMahon T., James K., Yasumoto T. Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon 2000, 38:917-930.
11. Ito E., Yasumoto T., Takai A., Imanishi S., Harada K. Investigation of the distribution and excretion of okadaic acid in mice using immunostaining method. Toxicon 2002, 40:159-165.
12. Ito E., Frederic M.O., Koftis T.V., Tang W., Petrovic G., Ling T., Nicolaou K.C. Structure toxicity relationships of synthetic azaspiracid-1 and analogs in mice. Harmful Algae 2006, 5:586-591.
13. LeHégarat L., Jacquin A.G., Bazin E., Fessard V. Genotoxicity of the marine toxin okadaic acid in human caco-2 cells and in mice gut cells. Environmental Toxicology 2006, 21(1):55-64.
14. Mukerjee R., Wu C.F.J. A Modern Theory of Factorial Design 2006, Springer Science and Business Media, New York.
15. Perez R., Rehmann N., Crain S., LeBlanc P., Craft C., MacKinnon S., Reeves K., Burton I.W., Walter J.A., Hess P., Quilliam M.A., Melanson J.E. The preparation of certified calibration solutions for azaspiracid 1, -2 and -3, potent marine biotoxins found in shellfish. Analytical and Bioanalytical Chemistry 2010, 398:2243-2252.
16. Quilliam M.A., Hess P., Dell'Aversano C. Recent development in the analysis of phycotoxins by liquid chromatography-mass spectrometry. Mycotoxins and phycotoxins in perspective at the turn of the Millennium. Proceedings of the Xth International IUPAC Symposium on Mycotoxins and phycotoxins, Brasil 2000 2001, 383-391. W.J. De Koe, R.A. Samson, H.P. van Egmond, J. Gilbert, M. Sabino (Eds.).
17. Rehmann N., Crain S.M., Perez R.A., Walter J.A., Hess P., Quilliam M.A. NRC CRM-AZA1, a Certified Calibration Solution for Azaspiracid-1 July 2007, CRMP Technical Report CRM-AZA1-20060719, National Research Council Canada, Halifax, Canada.
18. Ronzitti G., Hess P., Rehmann N., Rossini G.P. Azaspiracid-1 alters the E-cadherin pool in epithelial cells. Toxicological Sciences 2007, 95:427-435.
19. Tubaro A., Sosa S., Carbonatto M., Altinier G., Vita F., Melato M., Satake M., Yasumoto T. Oral and intraperitoneal toxicity studies of yessotoxin and homoyessotoxins in mice. Toxicon 2003, 41:783-792.
20. Twiner M.J., Hess P., Bottein Dechraoui M.-Y., McMahon T., Samons M.S., Satake M., Yasumoto T., Ramsdell J.S., Doucette G.J. Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian cell lines. Toxicon 2005, 45:891-900.
21. Zhou Y.C.F.J. Choice of designs and doses for early phase trials. Fundamental and Clinical Pharmacology 2004, 18:373-378.